Cas:606-83-7 3,3-Diphenylpropanoic acid manufacturer & supplier

We serve Chemical Name:3,3-Diphenylpropanoic acid CAS:606-83-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,3-Diphenylpropanoic acid

Chemical Name:3,3-Diphenylpropanoic acid
CAS.NO:606-83-7
Synonyms:MFCD00002717;EINECS 210-125-4;3,3-Diphenylpropanoic acid;Benzenepropanoic acid, β-phenyl-
Molecular Formula:C15H14O2
Molecular Weight:226.270
HS Code:2916399090

Physical and Chemical Properties:
Melting point:151-154 °C(lit.)
Boiling point:358.3±11.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.588
PSA:37.30000
Exact Mass:226.099380
LogP:3.38

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like MFCD00002717 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenepropanoic acid, β-phenyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 210-125-4 Use and application,3,3-Diphenylpropanoic acid technical grade,usp/ep/jp grade.


Related News: The move follows a Class I recall, the FDA’s most serious, launched by Innova in late April amid “significant concerns” about the test’s accuracy—and alongside an official warning letter delivered to the company this week. 3,3-Diphenylpropanoic acid manufacturer In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. 3,3-Diphenylpropanoic acid supplier Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells. 3,3-Diphenylpropanoic acid vendor The FDA approval allows Biogen to sell its product over several years – with forecasts for potential annual sales reaching as high $10 billion to $50 billion – until the company completes a required follow-up study. 3,3-Diphenylpropanoic acid factory The move follows a Class I recall, the FDA’s most serious, launched by Innova in late April amid “significant concerns” about the test’s accuracy—and alongside an official warning letter delivered to the company this week.